September 27­28, 2013 Detroit Marriott at the Renaissance Center

BS Y L L A B U S

• Program• Faculty and Disclosures

• Instructions for CME Credit• Learner Objectives

• Learner Bill of Rights

th

C O N F E R E N C EA N N I V E R S A R Y

Jointly sponsored by the American College of Cardiology FoundationProduced in cooperation with:

2

■ Accreditation and DesignationThis activity has been planned and implemented in accordance with the EssentialAreas and policies of the Accreditation Council for Continuing Medical Educationthrough the joint sponsorship of the American College of Cardiology Foundationand the Michigan Chapter of the American College of Cardiology. The AmericanCollege of Cardiology Foundation is accredited by the ACCME to providecontinuing medical education for physicians.

The ACCF designates this live educational activity for a maximum of 13.25 AMAPRA Category 1 Credit(s)™. Physicians should only claim credits commensuratewith the extent of their participation in the activity.

While offering credits noted above, this program is not intended to provideextensive training or certification in the field.

NURSESThe ACCME is approved by the Board of Nursing as an acceptable provider ofcontinuing education for license renewal and relicensure.

■ Instructions for CME Credit and Program EvaluationThe American College of Cardiology Foundation (ACCF) will e-mail each participantan online evaluation. Upon completion of the evaluation, the participant willreceive the CME certificate via the e-mail provided. If you do not receive an e-mailfrom the ACCF within seven business days following the conference, please contactthe Michigan Chapter at ddrago@dmsevents.com.

■ AcknowledgmentsThe Michigan Chapter ACC expresses appreciation to the following companies that have provided educational grants for this conference:

Gilead Sciences, Inc.

Maquet

St. Jude Medical

The Chapter expresses appreciation to the following companies for exhibiting at this conference:

Abbott Vascular

Abiomed, Inc.

Amarin Pharma, Inc.

American Heart Association

Astellas Pharma US

AstraZeneca

Biotronik

Boehringer­Ingelheim

Bristol­Myers Squibb

CardioNet

CFI Medical Solutions

Daiichi Sankyo

Edwards Lifesciences

Esaote

Gilead Sciences, Inc.

Janssen Pharmaceuticals

Kaneka Pharma America, LLC

C O N F E R E N C EA N N I V E R S A R Y

MICHIGAN CHAPTER OF THE AMERICAN COLLEGE OF CARDIOLOGY

Lantheus Medical Imaging

LifeWatch Services, Inc.

Lilly USA

Medical Billing Resources

Medtronic

Merck & Co.

ModuleMD

Munson Healthcare

OTSUKA America Pharmaceutical, Inc.

Pfizer, Inc.

Philips Healthcare

St. Jude Medical

The Medicines Company

Thoratec Corporation

Volcano

ZOLL LifeVest

Michigan Chapter of the American College of Cardiology11793 VFW RoadEaton Rapids, MI 48827­9708517­663­6622www.accmi.org

Welcome to the 25th Anniversary Celebration!

The Reunion Reception will kick off the evening. Reunite with colleagues from your training program and catch up with colleagues who have moved away fromMichigan or just across town. Exhibits of Michigan’s hospitals and traininginstitutions will provide the perfect place to rendezvous.

Following our 25th anniversary dinner, enjoy an informal conver sation withMichigan cardiologists who have scaled the highest levels of the pantheon ofcardiology. Emcee Dr. Douglas Weaver will interview four legendary figures in the arenas of public policy, research, academic cardiology and clinical cardiology.

FRIDAY, SEPTEMBER 27

6:00 PM Reunion Reception7:00 PM Anniversary Dinner and Michigan Legends of Cardiology9:30 PM Dessert Afterglow

Sidney Goldstein, MD was recruited to be thechief of cardiology for the Henry Ford Hospitalmore than 30 years ago. He is a superb clinicianand is internationally renowned for research on theuse of beta blockers following myocardialinfarction. He maintains an active research careerto this day.

Bertram Pitt, MD revitalized and expanded thedepartment of cardiology at the University ofMichigan when he arrived from Johns Hopkins inthe late 1970s. He is the lead investigator andauthor of numerous seminal research trials. Heestablished the subspecialty orientation of thecardiology section, which formed the basis of thecurrent Cardiovascular Center.

If William Beaumont, Royal Oak, is nowsynonymous with expertise in clinical cardiology, itis largely due to the vision, energy and clinicalskills of Gerald Timmis, MD. With his long-timeassociate Seymour Gordon, MD, he proved thatquality cardiology care is not just the province ofthe academic center.

When Wayne State University needed to replaceArnold Weissler, MD, as chief of cardiology, theyfound an up-and-coming star, Joshua Wynne, MD.In turn, he recruited a team of the brightest andbest young physicians to join him at the DMC. Dr.Wynne later saw the need for focused training inbusiness and health care management to meet thecomplexities of a rapidly changing medical field.

Thank you to our co-hosts:

GOLD LEVEL SILVER LEVEL

A 25th anniversary is cause for celebration!

3

4

1:00–5:30 PM ➤ BRULE, LEVEL 5

❚Opportunities are Knocking: Do you know how to answer?A Cardiovascular Leadership Workshop

Ms. Nicole KnightMr. Joel Sauer

1:00–1:15 PM Welcome and Introductions

1:15–2:45 PM Megatrends Impacting Healthcare & Cardiology• Cardiology Compensation &

Production Benchmark Data• Trends in Physician/Hospital

Alignment

2:45–3:15 PM Regulatory Program Updates

• Healthcare Reform• Meaningful Use: Stages 1–3• Value Based Modifier• Impacts of Incentives and Penalties

3:15–3:30 PM Break

3:30–4:00 PM Testing Volume Trends: Update on ACC Appropriate Use Criteria

4:00–4:45 PM Coding and Documentation from aStrategic Perspective

4:45–5:30 PM Facilitated Open Discussion

2:00–3:00 PM➤ CADILLAC, LEVEL 5

❚Cardiac CareTeam PosterCompetitionJoin the panel of judges as theyquery authors and judge posterspresented byMichigan RNs and APNs.

See page 7 for alist of the posterpresentations.

2:00–5:30 PM➤ LASALLE, LEVEL 5

❚FIT CaseCompetitionEnjoy 12 newchal leng ing casepresen ta tions inthis 17th annualFellows CaseCompetition.

See page 7 for alist of the casepresentations.

2:00–5:30 PM➤ CABOT, LEVEL 4

❚FIT PosterCompetitionJoin the panel of judges as theyquery authors and judge fellows-in-training (FIT)posters in the23rd annualFellows PosterCompetition.

See page 8 for alist of the posterpresentations.

9:00–11:45 AM | FIT Exclusive: Adult Congenital Heart Disease Seminar and Board Review ➤ AMBASSADOR I­II, LEVEL 5Drs. Timothy Cotts, William Davidson, Julie Kovach

9:00–9:30 Acyanotic Congenital Heart Disease9:30–10:00 Cyanotic Congenital Heart Disease 1

10:00–10:30 Cyanotic Congenital Heart Disease 210:30–10:45 Break10:45–11:45 Board Review/Case Discussions

11:45–1:45 PM | FIT Luncheon: Crafting Your Future ➤ AMBASSADOR I­II, LEVEL 5Michelle Bayer, Esq., Drs. Nancy Mesiha, W. Douglas Weaver, Stuart WinstonHow will the new landscape of healthcare affect your career choices? What are the critical elements in an employmentcontract? What tools do you need to negotiate? Learn from the experts at this session designed with ample time for Q&A.

1:00–5:30 PM ➤ NICOLET, LEVEL 5

❚The Art of Letting the PatientDo Things Your WayA Motivational InterviewingWorkshop

Dr. Ken Resnicow

Learn how to help patients work throughtheir ambiva lence about behavior change.Motivational Interviewing (MI) relies onreflective listening more so than directquestions, persuasion, or provision of advice.Originally developed for the treatment ofaddictive behaviors, MI has recently beenutilized for chronic disease, smokingcessation, diet, physical activity, diabetesmanagement, and medical adherence.

vF R I D A Y

Presented by Michigan Cardiology Fellows Society and

❚Reunion Reception ➤ RENAISSANCE FOYER, LEVEL 4❚Gala Dinner ➤ COLUMBUS BALLROOM, LEVEL 4

A Conversation with Michigan Legends in Cardiology Bertram Pitt, MD | Sidney Goldstein, MD | Gerald Timmis, MD | Joshua Wynne, MD Emcee: W. Douglas Weaver, MD

❚Afterglow ➤ RENAISSANCE FOYER, LEVEL 4

v2 5 t h A N N I V E R S A R Y C E L E B R A T I O N6:00–10:00 PM

v v

v

See complete details on page 3

❚ CLINICAL CARDIOLOGY ➤ LASALLE, LEVEL 5Stop! In the Name of ♥

Implementation of the latest evidence to assist patientsachieve healthy behavior patterns in coronary heart disease and heart failure management will require a newset of tools to replace the good intentions of a prior era.

Moderator: Dr. Michael Shea

10:00–10:20 AM Traditional and Emerging Risk FactorsDr. George Abela

10:20–10:40 AM Research Evidence for Benefits ofRisk Reduction

Dr. Peter McCullough

10:40–11:10 AM What Works: Successful Interventionswith Diet, Physical Activity, Smoking,Anger, Stress and Depression

Dr. Barry Franklin

11:10–11:30 AM Effective CommunicationDr. Sandra Oliver-McNeil

11:30–12:10 PM Reducing Heart Failure Readmissions:Tools that Work

Dr. Joy PollardDr. Dino Recchia

12:10–12:30 PM Panel Discussion

5

❚ INTERVENTIONAL CARDIOLOGY➤ CARTIER BALLROOM, LEVEL 4I Heard it Through the Grapevine

A journey through the past, present and future of quality improvement in Interventional Cardiology.

10:00–10:20 AM Clinical Lessons from BMC2­ PCI Dr. Hitinder Gurm

10:20–10:40 AM How Do I Use Platelet Function Testsin My Practice?

Dr. Vishal Gupta

10:40–11:00 AM Clinical Lessons from BMC2 VICDr. P. Michael Grossman

11:00–11:30 AM Break

11:30–11:50 AM Ten Best Interventional Papersfrom 2012

Dr. Herbert Aronow

11:50–12:10 PM Cardiac Catheterization Laboratory: My 25 Year Journey

Dr. Shukri David

12:10–12:30 PM The Future of Interventional Cardiology

Dr. Nicklaus Slocum

Presented by

❚ ECHOCARDIOGRAPHY ➤ CADILLAC, LEVEL 5Echo Motown

A series of challenging echo cases.

10:00–11:15 AM Moderator: Dr. David Forst

Expert Panel: Drs. Luis Afonso, Michael Gallagher, Michael Vredenburg

Unexplained Hypotension In the ICUDr. Mouhamad Mansour

Guidance of MV Structural InterventionDr. Dee Dee Wang

Post MI Cardiogenic ShockDr. Sidak Pal Panaich

Septal Defect Closure GuidanceDr. Sibin Zacharias

11:30–12:30 PM Moderator: Dr. Luis Afonso

Expert Panel: Drs. William Armstrong, Gerald Cohen, David Forst

A Patient with Unexplained Heart FailureDr. Gillian Grafton

Athlete with Abnormal EKGDr. Nikhil Ambulgekar

A Patient with an Unusual Cardiac MassDr. Nithin Gottam

Post Cardiac Surgery Hemodynamic CollapseTBA

Presented by

vS A T U R D A Y M O R N I N G6:00–7:00 AM | 5K on the RiverWalk

Meet in hotel lobby by 6:00 AM

7:00–7:45 AM | Early Coffee ➤ RENAISSANCE FOYER, LEVEL 4

7:45–8:00 AM | Welcome ➤ COLUMBUS BALLROOM, LEVEL 4

8:00–8:40 AM | Adult Congenital Heart Disease: Five Things Every Cardiologist Should Know ➤ COLUMBUS BALLROOM, LEVEL 4Dr. William Davidson, Jr.One in 150 adults in the US has congenital heart disease, but many are falling between the cracks. How do we ensure that these complex patients seek and receive appropriate care throughout their lives?

8:40–9:30 AM | KEYNOTE: Yes We CAN Treat Stable Ischemic Heart Disease with Optimal Medical Therapy ➤ COLUMBUS BALLROOM, LEVEL 4Dr. William BodenOptimal medical therapy is as good as or better than PCI for many patients with CAD. The challenge is to define the best strategy for an individual patient, based on scientific evidence drawn from the experience of thousands of patients.

9:30–10:00 AM | Breakfast with Exhibitors ➤ RENAISSANCE FOYER, LEVEL 4

10:00–12:30 PM |

12:45–2:15 PM

❚ ACIC Data CoordinatorLunch and Meeting ➤ NICOLET, LEVEL 5

❚ BMC2 Data CoordinatorLunch and Meeting➤ CABOT, LEVEL 4

Meetings for data coordinatorsand data abstractors with a focuson process improvement.

6

2:45–3:45 PM

❚BMC2 PCI PhysicianMeeting ➤ BRULE, LEVEL 5

A review of BMC2 qualityimprovement initiatives forBMC2 PCI physician champions.

2:45–5:15 PM

❚ARRHYTHMIA ISSUES IN GENERAL CARDIOLOGY ➤ CARTIER BALLROOM, LEVEL 4Function at the Junction

New research and emerging data give us new decision points as fast as they resolveolder questions. The successful management of patients with rhythm disorders now relieson close interaction between clinical cardiologists, electrophysiologists, cardiac careproviders and the patients themselves.

Chairs: Dr. George Klein and Dr. Sohail Hassan

2:45–3:15 PM ECG Abnormalities in the Asymptomatic Individual: When to Worry?

Dr. George Klein3:15–3:45 PM Rhythm Control is Better than Rate Control in Atrial

Fibrillation: Has the Controversy Ended?Protagonist: Dr. Dipak ShahAntagonist: Dr. Nilofar Islam

3:45–4:00 PM Lead Recalls, ICD and Cardiac Resynchronization Therapy Update

Dr. Claudio Schuger

4:00–4:10 PM Discussion4:10–4:40 PM Anticoagulation: A Debate

Coumadin is Obsolete, New Anticoagulants Are Better Dr. Randy Lieberman

Not So Fast, Coumadin Has a Role Dr. Ali Shakir

4:40–4:55 PM Atrial Fibrillation Ablation: Guidelines Applied to PracticeDr. Frank Pelosi, Jr.

4:55–5:15 PM Closing Case/Audience DiscussionDr. George Klein

2:45–3:45 PM

❚ACIC Physician Meeting ➤ NICOLET, LEVEL 5

Business meeting for physician champions, datacoordinators and nursing staff of the AdvancedCardiovascular Imaging Consortium (ACIC) withreview of data and discussion of ongoing qualityinitiatives.

3:45–5:15 PM

❚ ADVANCED CARDIAC IMAGINGUptight and Out of Sight➤ CABOT BALLROOM, LEVEL 4

Imaging has proven to be the cornerstone of themanagement of severe aortic stenosis. The hemo -dynamic cardiac catheterization has been replacedby new echo techniques and advanced cardiacimaging. This breakout session will focus on thecentral role of imaging in the performance andassessment of TAVR procedures.

3:45–4:10 PM CT and TAVR: How­To and What For

Dr. Jonathon Leipsic

4:10–4:35 PM TAVR—State of the ArtDr. George Hanzel

4:35–5:15 PM Case PresentationsDrs. Michael Gallagher,George Hanzel, JonathanLeipsic and William Mehri

Presented by

12:45–1:05 PM | Luncheon ➤ COLUMBUS BALLROOM, LEVEL 4

1:05–2:35 PM | All the Angles on Aortic Stenosis ➤ COLUMBUS BALLROOM, LEVEL 4Drs. Amr Abbas, William O’Neill, Himanshu Patel, Souheil SabaModerator: Dr. David Langholz It is a new era for patients with aortic stenosis. We have moved from a focus on the aortic valve itself to acomprehensive view that calls for a whole new set of diagnostic parameters. The advent of minimally invasivevalve replacement opens new areas for collaboration among surgeons, interventional cardiologists, andclinical cardiac care providers.

vS A T U R D A Y A F T E R N O O N

7

FIT Oral Case Competition

MODERATOR:Nancy Mesiha, MBChB, FACC, FIT Advisor

JUDGES:Michael Romanelli, MD, FACC, St. John Hospital and Medical CenterStuart Winston, DO, FACC, St. Joseph Mercy Hospital — Michigan Heart Division

2:00­2:05 Welcome

2:05­2:20 A 59 Year­Old Man with Unexplained HypoxemiaScott Allen, MD, University of Michigan

2:20­2:35 DES Avoids Multiple Coronary Interventions: Myth or Fact?Mohammad Alqarqaz, MD, Henry Ford Health System

2:35­2:50 A Case of Shocked Sad Heart!Mershed Alsamara, MD, Providence Hospital and Medical Centers

2:50­3:05 The Runaway Defibrillator…Mahmoud Assaad, MD, Providence Hospital and Medical Centers

3:05­3:20 Palpation of Asymmetric Pulses and a Startling DiagnosisPierre Charbel Atallah, MD, William Beaumont Hospital

3:20­3:35 Recurrent Syncopal Episodes in a Young Athlete: What next?Sandeep Banga, MD, Meijer Heart Center

3:35­3:50 Break

3:50­4:05 Dyspnea on Exertion: Is Left Ventricular Function the Whole Story?Tiberio Frisoli, MD, Henry Ford Health System

4:05­4:20 It’s an MI Not CAD!Ramanjit Kaur, MD, Wayne State University

4:20­4:35 Straight through The Heart!Yazan Khouri, MD, Oakwood Hospital

4:35­4:50 Everything Is Relative Even Potassium Levels!Keerthy Narisetty, MD, Michigan State University

4:50­5:05 Bridging an Interruption? Occasionally Adults Need It Too!Shikha Sharma, MD, Wayne State University

5:05­5:20 When the Cure Becomes the Disease.. .Abdulbaset Sulaiman, MD, Wayne State University

5:20­5:30 Closing Discussion

Cardiac Care Team PostersJUDGES:

Larry M. Diamond, PharmD, Oakwood Hospital and Medical CenterGinger K. Stewart­Biesbrock, PA­C, AACC, West Michigan Heart,

Member of Spectrum HealthTara L. Walker, DNP, RN, Wayne State University

VA Ann Arbor Healthcare System Cardiac Rehabilitation Program: One­Year OutcomesDenise Adams, RN, MSN, ACNS­BC, VA Ann Arbor Healthcare System

Transition RN Coordinator: Impact on ReadmissionsAngela Budai, RN, Henry Ford Health System

Psychosocial Factors Influencing Readmission Rates in Heart Failure PatientsCatherine Draus, RN, MSN, Henry Ford Health System

Getting to Normal: Women’s Experiences of Self­Managing Perceived BloodPressure ChangesMary M. Franklin, PhD, RN, ACNP­BC, Wayne State University

Improvement of Registered Nurse Knowledge of Heart Failure Self Care Measures through a Standardized Education Model (IKNOWHF MODEL)Janet Wyman, DNP, RN, ACNS­BC, AACC, Henry Ford Health System

8

FIT PostersJUDGES:

Thomas Forbes, MD, FACC, Children’s Hospital of MichiganDavid Lanfear, MD, MS, FACC, Henry Ford Health System

High Dose Beta Blocker Use Does Not Increase the Frequency of Allergic ContrastReaction in Coronary CT Angiogram (CTA) Examinations: Results from theAdvanced Cardiovascular Imaging Consortium (ACIC)Anshul Aggarwal MD, William Beaumont Hospital

Association of Left Ventricular Mechanical Dyssynchrony (LVMD) in Single­PhotonEmission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)With Left Ventricular Hypertrophy (LVH)Omaima Ali, MD, Wayne State University/ Detroit Medical Center

“DRAPE” Study: Same Day Dual Radial Artery Puncture Examination in PatientsRequiring PCI — Incidence of Radial Artery OcclusionSachin Kumar Amruthlal Jain, MD, Providence Hospital and Medical Centers

Comparison of the HAS­BLED, ATRIA and HEMORR2HAGES Scores to the CHADS2Score for Bleeding Risk in Atrial Fibrillation Patients on Warfarin Therapy: TheMichigan Anticoagulation Quality Improvement Initiative (MAQI2) ExperienceGeoffrey Barnes, MD, University of Michigan

Triple Rule­Out vs. Coronary CT Angiography in patients with Acute Chest Pain:Results from the Advanced Cardiovascular Imaging Consortium (ACIC)Alfred C. Burris II, MD, William Beaumont Hospital

Biventricular Implantation and Improvement in Creatinine after Device (BI­V ICD)Daniel Brancheau, DO, Providence Hospital and Medical Centers

Radial Re­puncture vs. Femoral Crossover Access Safety in Percutaneous CoronaryIntervention (PCI) for Transferred Patients (RAFAS)Ahmad Daraghmeh, MD, Providence Hospital and Medical Centers

Implanted Cardioverter Defibrillator Shock Risk and Mortality in Women withAdriamycin­induced CardiomyopathyMaria Elena De Benedetti Zunino, MD, Henry Ford Health System

Predictors of Technical Success of Percutaneous Revascularization of ChronicTotal Occlusions in De Novo Superficial Femoral Arterial Lesions in the CurrentEra: A Paradigm Shift?Rony Gorges, MD, Providence Hospital and Medical Centers

Primary Care Physicians and Cardiologists: Recognizing and Bridging the Gaps inLipid ManagementUsman Hashmi, MD, St John Hospital and Medical Center

Validation of QT Interval as Measured by Smart Phone Recorder with Comparisonto Standard 12­ Lead EKGRami Heart, DO, St John Health­ Macomb

Evaluation of Appropriate Use of SPECT Myocardial Perfusion Imaging in an Inner­City Academic Hospital SettingRamanjit Kaur, MD, Wayne State University/ Detroit Medical Center

Single Versus Dual Chamber Implantable Cardioverter Defibrillators: Are SingleChamber Devices Really Obsolete?Akif Mohammed, MD, Henry Ford Health System

Is Renal Artery Stenting Still Relevant in 2013? A Cohort Analysis (RASCAL Trial)Sunil Naik, MD, Providence Hospital and Medical Centers

CHA2DS2­VASc Versus CHADS2 for Stroke Risk Assessment in Low­risk Patients with Atrial Fibrillation: A Pilot Study from a Single Center of the NCDR­PINNACLE RegistryChatchawan Piyaskulkaew, MD, St John Hospital and Medical Center

Does Gender Play an Impact in Management Post Acute Myocardial Infarction?Roshni Shah, DO, Southfield Providence Hospital and Medical Centers

Fluoroscopic Investigation of Riata Transvenous Defibrillator Leads: Prevalenceand Predictors of Lead ExternalizationGurjit Singh, MD, Henry Ford Health System

Prevalence and Characteristics of Diabetic Patients with Mixed Dyslipidemia WhoMay Benefit from Combination Statin­fibrate Therapy Referred to a SpecialtyLipid Management ProgramDeepthi Vodnala, MD, St John Hospital and Medical Center

Safety Profile of Cardiac CT Angiography in the Advanced Cardiovascular Imaging Consortium (ACIC)Sibin Zacharias, MD, William Beaumont Hospital

Cystatin C and Reclassification of Coronary Heart Disease Deaths among LargeMultiethnic Nationally Representative CohortsSandip Zalawadiya, MD, Wayne State University/ Detroit Medical Center

9

P L A N N I N G C O M M I T T E E & F A C U L T Y

9

KEYNOTEWilliam E. Boden, MD, FACC, FAHAChief of Medicine, Samuel S. Stratton VA Medical CenterVice-Chairman, Department of Medicine, Albany Medical Center

Dr. Boden has worked extensively in the clinical trials arena of non-Q-wave MIand in assessing the role of calcium antagonists in patients with ischemic heartdisease, notably in non-Q-wave MI secondary prevention. Dr. Boden was studychairman for the VANQWISH trial and study co-chair for INTERCEPT trial. TheCOURAGE trial, for which he is co-chair and lead author, is the largest randomized

trial comparison of PCI vs optimal medical therapy in stable CAD patients. He also co-chaired theAIM-HIGH trial to evaluate the long-term role of combination dyslipidemic therapy (niacin andstatin vs statin) in CAD patients with low HDL-cholesterol.

GUEST FACULTYWilliam R. Davidson, Jr., MD, FACCDirector, Program for Adult Congenital Heart Disease (PACHD)Penn State Hershey Heart and Vascular Institute

Dr. Davidson trains Penn State Hershey FITs in a monthly ACHD rotation and recentlytook the program's first trainee in a new two-year ACHD fellowship. He is also Directorof Echocardiography with a special interest in imaging of ACHD and was a sub-investigator for the RESPECT trial. Dr. Davidson serves on the Adult Congenital HeartAssociation (ACHA) Medical Advisory Board and the International Society for AdultCongenital Heart Disease Executive Committee.

George J. Klein, MD, FRCPC Professor of MedicineUniversity of Western Ontario

Dr. Klein’s research focus has been in cardiac arrhythmia with contributions to thenatural history and management of the Wolff-Parkinson-White syndrome, the operativeand ablative management of arrhythmias and the understanding of clinical syncope.He is the inventor of the implantable loop recorder (Reveal rx) and holds 10 USpatents.

Jonathan A. Leipsic, MD, FRCPC, FSCCT Chair, Department of RadiologyCo-Director, Advanced Cardiac ImagingProvidence Health Care Heart Center at St. Paul’s Hospital

Vice Chair for Research, Assistant ProfessorDepartment of Radiology, University of British Columbia

Dr. Leipsic is actively involved in cardiac CT and MR research with prior involvementin a multi-center trial evaluating coronary CT angio graphy vs. QCA. His specialinterests include diagnostic perform ance and radiation reduction as well as CT toguide minimally invasive valve intervention.

KEYNOTEPLANNING COMMITTEE

GUEST FACULTY

Co-chairs: Felix J. Rogers, DO, FACCW. Douglas Weaver, MD, MACC

George S. Abela, MSc, MBA, MD, FACC

Luis Afonso, MBBS, FACC

Karthik Ananthasubramaniam, MBBS, FACC

Herbert D. Aronow, MD, MPH, FACC

Alice Betz

Kavitha Chinnaiyan, MD, FACC

Timothy B. Cotts, MD, FACC

Maria Elena DeBenedetti Zunino, MD

Simon Dixon, MBChB, FACC

Claire S. Duvernoy, MD, FACC

Barry A. Franklin, PhD, FACSM

Ruth Fisher

P. Michael Grossman, MD, FACC

Hitinder S. Gurm, MBBS, FACC

Sohail A. Hassan, MBBS, FACC

Andrea Jensen

David E. Lanfear, MD, MS, FACC

C. Douglas Lees, MBChB, FACC, FACS

Barry Lewis, DO, FACC

Peter McCullough, MD, MPH, FACC

Nancy A. Mesiha, MBChB, FACC

Darlene Nichols

Sandra Oliver-McNeil, DNP, NP, AACC

Joy A. Pollard, NP, PhD

Howard S. Rosman, MD, FACC

Roshni Shah, DO

Kathleen Shibley, RDCS, CCT, FASE

Christopher Simpson, MD, FACC

Michael C. Vredenburg, DO, FACC

Kim A. Williams, Sr., MD, FACC

David H. W. Wohns, MD, FACC

10

F A C U L T Y

Amr E Abbas, MD, FACC, FSCAI, FSVM, RPVI, FASE Beaumont Health System/Oakland University WilliamBeaumont School of Medicine

George S. Abela, MSc, MBA, MD, FACC Michigan State University

Luis C. Afonso, MBBS, FACC Detroit Medical Center/Wayne State University

Scott Allen, MDUniversity of Michigan

Mohammad Alqarqaz, MD Henry Ford Health System

Mershed Alsamara, MD Providence Hospital and Medical Centers

William F. Armstrong, MD, FACCUniversity of Michigan

Herbert D. Aronow, MD, MPH, FACC, FSCAI, FSVM St. Joseph Mercy Hospital-Michigan Heart Division

Mahmoud Assaad, MDProvidence Hospital and Medical Centers

Pierre Charbel Atallah, MDWilliam Beaumont Hospital

Sandeep Banga, MDMeijer Heart Center

Michelle D. Bayer, Esq.Vezina Law

Gerald I. Cohen, MD, FACCSt. John Hospital and Medical Center/Wayne State University

Timothy Cotts, MD, FACC University of Michigan

Shukri W. David, MD, FACC Providence Hospital and Medical Centers

Larry Diamond, PharmDOakwood Hospital and Medical Center

Thomas Forbes, MD, FACCChildren’s Hospital of MichiganDavid Forst, MD, FACC, FASE Beaumont Health System/Oakland University William Beaumont School of Medicine

Barry A. Franklin, PhD, FACSMWilliam Beaumont Hospital/Oakland University WilliamBeaumont School of Medicine

Tiberio Frisoli, MDHenry Ford Health System

Michael J. Gallagher, MD, FACCBeaumont Michigan Heart Group/ Oakland University WilliamBeaumont School of Medicine

P. Michael Grossman, MD, FACC, FSCAI VA Ann Arbor Health Systems/University of Michigan Health System

Hitinder S. Gurm, MBBS, FACC University of Michigan Health System

Vishal Gupta, MBBS, MPH, FACC Borgess Medical Center

George S. Hanzel, MD, FACC William Beaumont Hospital

Sohail A. Hassan, MBBS, FACCEastside Cardiovascular Medicine, PC/Wayne State University School of Medicine

Nilofar H Islam, MBBS, FACC, CEPS Mid-Michigan Medical Center/ Michigan State University

Ramanjit Kaur, MDWayne State University

Yazan Khouri, MDOakwood Hospital

Nicole F. Knight, LPN, CPC, CCSPMedAxiom, Inc.

Julie A. Kovach, MD, FACC, FASE Children’s Hospital of Michigan/Detroit Medical Center/Wayne State University School of Medicine

David E. Lanfear, MD, MS, FACCHenry Ford Health SystemDavid Langholz, MD, FACC Frederick Meijer Heart and Vascular Institute, SpectrumHealth/Michigan State University

Randy A. Lieberman, MD, FACC DMC Cardiovascular Institute

Peter A. McCullough, MD, MPH, FACC, FACP, FAHA, FCCP, FNKF St. John Providence Health System

William Merhi, DO, FACCWest Michigan Cardiology

Nancy A. Mesiha, MBChB, FACCSt. John Hospital and Medical Center

Sandra M. Oliver­McNeil, DNP, ACNP­BC, AACC Wayne State University

Keerthy Narisetty, MDMichigan State University

William O’Neill, MD, FACC, FSCAI Henry Ford Health System

Himanshu J. Patel, MDUniversity of Michigan Health System

Frank Pelosi, Jr., MD, FACC University of Michigan Health System

Joy A. Pollard, PhD, RN, CCRN, ACNP­BC St. Joseph Mercy Oakland

Dino Recchia, MD, FACC Traverse Heart & Vascular/ Munson Medical Center

Kenneth Resnicow, PhD University of Michigan School of Public Health

Michael Romanelli, MD, FACCSt. John Hospital and Medical Center

Souheil Saba, MD FACC Providence Hospital and Medical Centers/Wayne State University

Joel SauerMedaxiom, Inc.

Claudio D. Schuger, MD, FACC Henry Ford Health System

Dipak P. Shah, MD Providence Hospital and Medical Centers

Ali Shakir, MBBS, FACC Henry Ford Health System

Shikha Sharma, MDWayne State University

Michael J. Shea, MD, FACC, FACCPUniversity of Michigan

Nicklaus Slocum, MD Traverse Heart and Vascular/Munson Medical Center

Ginger K. Stewart­Biesbrock, PA­C, AACCWest Michigan Heart, Member of Spectrum Health

Abdulbaset Sulaiman, MD Wayne State University

Michael Vredenburg, DO, FACCFrederick Meijer Heart and Vascular Institute, Spectrum HealthTara L. Walker, DNP, RNWayne State University

W. Douglas Weaver, MD, MACC Henry Ford Health System

Stuart A. Winston, DO, FACCSt. Joseph Mercy Hospital-Michigan Heart Division

FACULTY

11

C M E I N F O R M A T I O N

■ Overall NeedCardiovascular disease is the leading cause of death in Michigan. The state’sresidents rank among the worst in the nation for rates of smoking, high bloodpressure, obesity, and diabetes. It is imperative that the cardiac care teamremain current on diagnosis and treatment of heart disease and continue toexplore optimum methods for the delivery and measurement of qualitycardiovascular care.

■ Overall GoalThe conference activities are designed to enhance learner competence bydiscovering strategies to anticipate research driven changes in practiceperformance, to further develop clinical skills that improve patient outcomes inrapidly evolving areas, and to identify new strategies for the delivery of qualitycardiovascular care. This opportunity provides needs based learning on issues ofprimary importance to the cardiac care team.

■ Target AudienceAdult CardiologistsPediatric CardiologistsCardiothoracic SurgeonsCardiology Fellows in TrainingInternal Medicine Residents

The entire cardiac care team, including but not limited to:Nurses, Nurse Practitioners, Clinical Nurse SpecialistsPhysician AssistantsPharmacistsCardiology Practice AdministratorsCV TechnologistsSonographersData Coordinators and Abstractors

Accredited status does not imply endorsement by the ACCF of any commercialproducts displayed in conjunction with this activity. ACCF reserves the right tomodify faculty and the program without notice.

■ Learner Bill of RightsThe American College of Cardiology Foundation (ACCF) recognizes that you are alife-long learner who has chosen to engage in continuing medical education toidentify or fill a gap in knowledge or skill; and to attain or enhance a desiredcompetency. As part of ACCF’s duty to you as a learner, you have the right toexpect that your continuing medical education experience with ACCF includes thefollowing: (You will be queried at the end of the activity regarding yourimpressions.)

Content that:

• Promotes improvements or quality in healthcare

• Is current, valid, reliable, accurate and evidence-based

• Addresses the stated objectives or purpose

• Is driven and based on independent survey and analysis of learnerneeds, not commercial interests

• Has been reviewed for bias and scientific rigor

• Offers balanced presentations that are free of commercial bias

• Is vetted through a process that resolves any conflicts of interest of planners and faculty

• Is evaluated for its effectiveness in meeting the identified educational need

A learning environment that:

• Is based on adult learning principles that support the use of variousmodalities

• Supports learners’ abilities to meet their individual needs

• Respects and attends to any special needs of the learners

• Respects the diversity of groups of learners

• Is free of promotional, commercial and/or sales activities

Disclosure of:

• Relevant financial relationships that planners, teachers and authorshave with commercial interests related to the content of the activity

• Commercial support (funding or in-kind resources) of this activity

12

■ ACCF Disclosure/Conflict of Interest Statement/Off-Label StatementAs a provider accredited by the Accreditation Council for ContinuingMedical Education (ACCME) and the American Nurses Credentialing Center(ANCC), the American College of Cardiology Foundation (ACCF) must ensurebalance, independence, objectivity and scientific rigor in all of their directlysponsored or jointly sponsored educational activities. Provider(s) andfaculty participating in a sponsored activity are required to disclose to theaudience any significant financial interests or other relationships he/she or amember of their immediate family may have (1) with the manufacturer(s) ofany commercial product(s) and/or provider(s) of commercial servicesdiscussed in an educational presentation and (2) with any commercialsupporters of the activity. ACCF is committed to providing its learners withhigh-quality activities and materials that promote improvements and qualityin health care and not a specific proprietary business or commercialinterest. The intent of this disclosure is not to prevent participation insponsored educational activities by persons with a financial or otherrelationship, but rather to provide learners with information on which theycan make their own determination whether financial interests orrelationships may influence the credited activity. Any individual refusing toprovide adequate disclosure consistent with this policy will be prohibitedfrom participation in any future ACCF education activities.

ACCF assesses conflict of interest (COI) with its faculty, planners, managers,staff and other individuals who are in a position to control the content ofCME/CNE-credited activities. All relevant potential conflicts of interest thatare identified are thoroughly vetted through a process that includes coursedirectors and appropriate peer review by education committeechairs/members, for fair balance, scientific objectivity and validity, andpatient care and safety recommendations.

ACCF also requires that all faculty presenters disclose their intent to discussany unlabeled/unapproved uses of drugs and/or devices during theirpresentations.

■ DisclaimersAbstracts, articles and slides related to this activity that are posted on theChapter’s website are posted with permission. This information is providedfor general medical education purposes only and is not meant to substitutefor the independent medical judgment of a clinician relative to diagnosticand treatment options for a specific patient’s medical condition.

The American College of Cardiology Foundation (ACCF) does not warrantthe completeness, accuracy or usefulness of any opinions, advice, servicesor other information provided through this activity. In no event will ACCFbe liable for any decision made, or action taken, in reliance upon theinformation provided through this activity.

C M E I N F O R M A T I O N

13

L E A R N I N G O B J E C T I V E SUpon completion of this program, attendees should be able to:

Cardiovascular Leadership Workshop: Opportunities areKnocking: Do You Know How to Answer?

•Review national data influencing healthcare generally andcardiology specifically.

•Review and identify industry trends specific to compensa-tion within the industry, along with corresponding data onphysician productivity.

•Review data on physician/hospital co-management agree-ments and full integration.

•Review current regulatory requirements and MeaningfulUse incentives.

•Review diagnostic testing trends over time and the up-dated ACC appropriate use and criteria guidelines.

•Review ICD-10 implementation requirements.

FIT Case Competition•Synthesize current science and cutting edge technology to

identify the optimum evidence-based treatment strategies.

Motivational Interviewing Workshop• Identify motivational interviewing techniques and describe

their value in helping improve cardiac health.

A Conversation with Michigan Legends in Cardiology•Describe the career path and achievements of legendary

Michigan cardiologists.

Yes We CAN Treat Stable Ischemic Heart Disease with Optimal Medical Therapy

•Review the ACC/AHA and ASCI guidelines for the manage-ment of patients with chronic angina pectoris and identifythe diagnostic and treatment strategies best suited forthe patient.

Adult Congenital Heart Disease: Five Things Every Cardiologist Should Know

•Review the ACC/AHA guidelines for the management of patients with adult congenital heart disease.

BMC2 PCI Data Coordinators Meeting• Identify and present hospital specific case studies where

quality improvement goals were achieved using a team approach.

ACIC Data Coordinators Meeting•Discuss gaps in ordering by referring physicians and develop

collaborative plans on improving the same. Discuss the im-pact of this activity on appropriate use per guidelines.

Clinical Lessons from BMC2­PCI•Describe results from the BMC2 PCI Registry and quality

improvement opportunities that can be identified from the data.

How Do I Use Platelet Function Tests in My Practice?•Describe how to effectively employ platelet function tests

to help determine the cause of or potential for excessivebleeding, to monitor and evaluate platelet function, and tomonitor the presence and effectiveness of antiplateletmedications.

Clinical Lessons from the BMC2 VIC•Describe results from the BMC2 VIC Registry and quality

improvement opportunities that can be identified from thedata.

Ten Best Interventional Papers from Last Year•Describe the hypotheses, findings and conclusions from

the ten most important manuscripts in interventional cardiol-ogy during the last year and discuss implications for the pro-vision of PCI and PVI interventions with optimal outcomes.

Cardiac Catheterization Laboratory – My 25 Year Journey•Describe the key developments in interventional cardiology

since the late 1980s. Explore which changes were advance-ments in patient care and why and which were not as successful and why.

The Future of Interventional Cardiology•Describe the latest developments in treatment of struc-

tural heart disease and new developments in pharmaco-therapy for the treatment of cardiovascular disease.

Clinical Cardiology: Stop! In the Name of ♥•Review the evidence base for traditional and emerging risk

factors for CAD. •Review the current publications and best practice models

that demonstrate effectiveness in promoting healthy lifestyle change by patients to achieve optimal medical treat-ment of CAD and reduce admissions for heart failure.

Echo Motown•Review the current publications and associations recom-

mendations for role of echo in ICU and in cardiac interven-tions, disease process and multimodality imaging.

All the Angles on Aortic Stenosis•Review the guidelines and research evidence from the

current publications in terms of the diagnosis and clinicalcourse of patients with severe aortic stenosis.

•Define the best practices for intervention, including tradi-tional surgery and percutaneous approaches.

CT and TAVR: How­To and What For•Review the randomized clinical trials that have established

TAVR as a treatment option for patients with severe aorticstenosis.

TAVR State of the Art •Describe the limitations and complications of TAVR, as well

as the strategies and device modifications being developedto manage these issues.

ECG Abnormalities in the Asymptomatic Individual: When to worry?

•Examine asymptomatic WPW pattern.•Differentiate RVOT VT from ARVC.

Rhythm Control is Better than Rate Control in Atrial Fibrillation: Has the Controversy Ended?

• Identify better which patients will be managed with rateversus rhythm control.

Lead Recalls/ICD/Cardiac Resynchronization Therapy Update

•Analyze the most current data on lead recalls for intra-cardiac defibrillators.

•Review the guidelines for cardiac re-synchronization therapy.

Anticoagulation: A Debate•Examine case scenarios where newer anti-coagulants

are beneficial. • Identify patients who are difficult to manage with

warfarin therapy alone and possible use of alternativemedication therapy.

Atrial Fibrillation Ablation: Guidelines Applied to Practice•Review current guidelines for invasive management

of atrial fibrillation.• Identify patients for atrial fibrillation ablation therapy.

Cardiac Electrophysiology Case• Investigate various case scenarios encountered in

management of difficult arrhythmia cases.

BMC2 PCI Physician Advisory Committee Meeting•Describe key indicators for cross-site sharing and approaches

to using the information for quality improvement •Describe how to participate in the state wide collaboration

as a “provider” of best practices and as a site “seeking” toidentify better approaches for addressing a specific qualityimprovement opportunity.

ACIC Physician Advisory Committee Meeting•Evaluate current appropriateness criteria for coronary CT

angiography use in patients with suspected coronary arterydisease with minimal risk.

•Discuss inappropriateness of CCTA in asymptomatic patientsand alternative modes of risk stratification to foster bestpractices for CCTA by advancing physician knowledge base.

C O M M I T T E E A N D F A C U L T Y D I S C L O S U R E

FACULTY OR COMMITTEE NAME CONSULTING FEES/ SPEAKER’S BUREAU OWNERSHIP, RESEARCH GRANTS SALARY OTHER FINANCIAL BENEFITHONORARIA PARTNERSHIP, ETC.

Amr Abbas, MD LantheusGeorge Abela, MD GlaxoSmithKline Amgen, Merck Karthik Ananthasubramaniam, MBBSWilliam Armstrong, MD Thoratec, Inc.William Boden, MD Abbott, Arbor Pharmaceutical,

Janssen Pharmaceuticalsand CardioDx

Sandra L. Chase, PharmD Otsuka America Pharmaceutical, Inc.

Gerald Cohen, MD Lantheus Medical ImagingTimothy B. Cotts, MD Actelion PharmaceuticalsShukri W. David, MD Boston Scientific,

St. Jude MedicalSimon R. Dixon, MBChB Abbott, Abiomed, Boston

Scientific, InfraReDxVishl Gupta, MBBS, MPH Boehringer Ingelheim, Lilly Janssen Pharmaceuticals Neuralieve, Merritt

Medical, ASI, Inc.Hitinder S. Gurm, MBBS Blue Cross Blue Shield of MichiganGeorge S. Hanzel, MD Gore Corp.Sohail Akhtar Hassan, MBBS Boehringer Ingelheim, Biotronik, Zoll Boston Scientific

Boston Scientific, Medtronic, St. Jude Medical, Sanofi Aventis

Andrea Jensen Blue Cross Blue Shield of Michigan

George Klein, MD Boston Scientific Biotronk, St. Jude Medical Bayliss (product development)

David E. Lanfear, MD Thoratec CardioRentis, Biocontrol, Amgen, NIH

Randy A. Lieberman, MD Janssen Pharmaceuticals, Medtronic, Pfizer

Jonathan Leipsic, MD Edwards Lifesciences, GE Healthcare Heartflow, Inc.

William W. O’Neill MD MedtronicHimanshu J. Patel, MD Edwards, Inc., W.L. Gore,

Medtronic Frank Pelosi, Jr., MD Spectranetics, Inc., St. Jude Biotronik Avicenna Medical Medtronic, Inc.

Medical, Boston Scientific Systems

Bertram Pitt, MD Gambro, Springleaf BG Medicine (stock), Relypsa (stock)Therapeutics, Bayer, Takeda, Novartis, Pfizer

Kenneth Resnicow, PhD VitalitySouheil Saba, MD Novartis, St. Jude MedicalClaudio D. Schuger, MD Boston Scientific, Medtronic,

St. Jude MedicalDipak P. Shah, MD Boehringer Ingelheim, Janssen

Pharmaceuticals, BiosenseWebster, Zoll, Sanofi

Michael J. Shea, MD Boehringer Ingelheim, Janssen Pharmaceuticals, Sanofi, Zoll

W. Douglas Weaver, MD Premier GlaxoSmithKline Boehringer Ingelheim, Boston Scientific, Mesoblast, Symetis, Co.,DCRI Trial sponsored by The Medicines Co.(data monitoring board for all)

Kim Allan Williams, Sr., MD Astellas Society for CV Computed Technology (officer)

David H. W. Wohns, MD Medicines Company, Terumo Medical

Lantheus Medical Imaging Astellas Pharma, LantheusMedical Imaging

Astellas Pharma GlobalDevelopment

14

15

C O M M I T T E E A N D F A C U L T Y D I S C L O S U R E

The following individuals have disclosed that they have no relevant financial relationships in regard to this program:

Luis Afonso, MDScott Allen, MDMohammad Alqarqaz, MDMershed Alsamara, MDNikhil Ambulgekar, MDHerbert Aronow, MDMahmoud Assaad, MDPierre Charbel Atallah, MDSandeep Banga, MDMichelle Bayer, Esq.Alice BetzThomas F. Boyden, Jr., MDKavitha Chinnaiyan, MDWilliam R. Davidson, Jr., MDAnn M. DePetris, RNClaire S. Duvernoy, MDRuth Fisher David H. Forst, MDBarry A. Franklin, PhDTiberio M. Frisoli, MDMichael J. Gallagher, MD

Sidney Goldstein, MDNithin Gottam, MDGillian Graftn, DOPaul Michael Grossman, MDNilofar H. Islam, MBBSRamanjit Kaur, MDYazan Khouri, MDNicole Knight, LPNJulie A. Kovach, MDDavid E. Langholz, MDBarry K. Lewis, DOChristian E. Machado, MDMouhamad Mansour, MDPeter A. McCullough, MDWilliam M. Merhi, DONancy A. Meshia, MBChBKeerthy K. Narisetty, MDDarlene NicholsSandra M. Oliver­McNeil, NPSidal Pal Panaich, MDJoy A. Pollard, PhD, ACNP­BC

Dino Recchia, MDFelix J. Rogers, DOMichael Romanelli, MDHoward S. Rosman, MDSouheil Saba, MDJoel SauerRoshni Mukesh Shah, MDAli Shakir, MDShikha Sharma, MDKathy Shibley, RDCS, CCTNicklaus Slocum, MDChristopher S. Simpson, MDAbdulbaset Sulaiman, MDGerald C. Timmis, MDMichael C. Vredenburg, DODeeDee Wang, MDStuart A. Winston, DOJoshua Wynne, MDSibin Zacharias, MDMaria Elena DeBenedetti Zunino, MD

16

N O T E S

17

N O T E S

18

N O T E S

19

N O T E S

C O N F E R E N C EA N N I V E R S A R Y

MICHIGAN CHAPTER OF THE AMERICAN COLLEGE OF CARDIOLOGY

25th Annual Conference of the Michigan Chapter of the American College of Cardiology

September 27~38, 2013 • Detroit Marriot at the Renaissance Center

Floor Plan of Detroit Marriott at the Renaissance Center

LEVEL 5

LEVEL 4